29 Apr 2026
3m
Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio
CNBC Television
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.